Life Science News

Receives First Significant Order Validating Strategy of Focusing on School Districts Nationwide as the Federal Government Deploys Billions of Dollars for Improving Indoor Air Quality

Applied UV, Inc. (NasdaqCM: AUVI ) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly and automatically, announces that both its Airocide™ and its Scientific Air™ S400 (by SteriLumen ) have been purchased for placement in the St. Joseph, Missouri School District. The school district serves 24 schools and over 10,600 students. The initial deployment of the units will be within the high schools with additional orders expected for the middle and elementary schools.

This initial order totals $625,000 and is expected to be delivered to the customer and recognized as revenue in the second half of 2022.

Mickey Gill, Director of Operation and Warehousing, St. Joseph, Missouri School District, commented, "We are committed to supporting all of our students and staff not only in academics but also with a clean and safe environment for learning. The Scientific Air™ S400 eliminates up to 99.99 percent of airborne viruses in minutes (including bacteria, mold, odors and VOCs). Providing a healthy learning environment is beneficial for everyone."

Ben Rendo, MightyGood's Chief Executive Officer, commented, "MightyGood is proud to partner with Applied UV to provide air purification solutions to the education sector. The Airocide™ technology, which was designed for NASA, helps us provide students with healthcare grade air purification in classrooms across the country."

John F. Andrews, Applied UV's Chief Executive Officer, commented, "The St. Joseph order is the first significant order of our products in a K-12 school environment. Additionally, the procurement process, in the State of Washington, where we previously announced that our partner DA International was included in a multi-million-dollar contract which includes our Airocide™ air purification systems has recently commenced, and we have already submitted about $300,000 in quotations which we expect decisions on soon. The total addressable market in Education that our suite of Airocide™ and Scientific Air™ solutions address represents a massive dollar opportunity and is a high priority vertical. We applaud school districts that are taking proactive action to improve learning and working environments and are encouraged by the momentum we are building in this important sector."

Follow us on Twitter
Follow us on LinkedIn

About Applied UV

Applied UV is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly owned subsidiaries - SteriLumen, Inc. ("SteriLumen") and Munn Works, LLC ("Munn Works"). SteriLumen's connected platform for Data Driven Disinfection™ applies the power of ultraviolet light (UVC) to destroy pathogens safely, thoroughly, and automatically, addressing the challenge of healthcare-acquired infections ("HAIs"). Targeted for use in facilities that have high customer turnover such as hospitals, hotels, commercial facilities, and other public spaces, the Company's Lumicide™ platform uses UVC LEDs in several patented designs for infection control in and around high-traffic areas, including sinks and restrooms, killing bacteria, viruses, and other pathogens residing on hard surfaces within devices' proximity. The Company's patented in-drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical pathogen intensive location. SteriLumen's Airocide® air purification devices are research backed, clinically proven and developed for NASA with assistance from the University of Wisconsin. Airocide® is listed as an FDA Class II Medical device, utilizes a proprietary photocatalytic (PCO) bioconversion technology that draws air into a reaction chamber that converts damaging molds, microorganisms, dangerous airborne pathogens, destructive VOCs, allergens, odors and biological gasses into harmless water vapor and green carbon dioxide without producing ozone or other harmful byproducts. Airocide® applications include healthcare, hospitality, grocery chains, wine making facilities, commercial real estate, schools, dental offices, post-harvest, grocery, cannabis facilities and homes. For more information about Applied UV, Inc., and its subsidiaries, please visit the following website: https://www.applieduvinc.com/ .

Forward-Looking Statements

The information contained herein may contain "forward-looking statements." Forward-looking statements reflect the current view about future events. When used in this press release, the words "anticipate," "believe," "estimate," "expect," "future," "intend," "plan," or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements include, but are not limited to, statements contained in this press release relating to the view of management of Applied UV concerning its business strategy, future operating results and liquidity and capital resources outlook. Forward-looking statements are based on the Company's current expectations and assumptions regarding its business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company's actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Factors or events that could cause the Company's actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

Applied UV Inc.
John F. Andrews
Applied UV CEO, Director
john.andrews@applieduvinc.com

Brett Maas, Managing Principal
Hayden IR
brett@haydenir.com
(646) 536-7331

News Provided by Business Wire via QuoteMedia

AUVI:NSD
Bloom Health Partners Announces Leadership Transition

Bloom Health Partners Announces Leadership Transition

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of diagnostic and health technology services, announces a leadership transition.

Effective September 30, 2022, Andrew Morton has stepped down as CEO of the Company to pursue other opportunities. Rosemary Elliston, COO of the Company, has been appointed to the position of Interim CEO. Mr. Morton will continue to support the Company as a Director.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
PowerTap Hydrogen Announces That Its 49% owned subsidiary, Progressus Clean Technologies Has Executed a Letter of Intent with Alkaline Fuel Cell Power Corp. for Clean Hydrogen Joint Venture Pilot

PowerTap Hydrogen Announces That Its 49% owned subsidiary, Progressus Clean Technologies Has Executed a Letter of Intent with Alkaline Fuel Cell Power Corp. for Clean Hydrogen Joint Venture Pilot

  • Pilot project to provide in-field proof of concept and operational data
  • Advancing a potential solution for global utility companies to blend hydrogen and natural gas
  • JV structured to support potential future growth and additional partnerships

PowerTap Hydrogen Capital Corp. (NEO: MOVE) (FWB: 2K6) (OTC: MOTNF) ("PowerTap" or the "Company" or "MOVE") is pleased to provide an update and details on Progressus Clean Technologies Inc. ("Progressus") entering into a letter of intent with Alkaline Fuel Cell Power Corp. (NEO: PWWR) (OTCQB:ALKFF) (Frankfurt: 77R, WKN: A3CTYF) ("AFCP") to complete a joint venture ("JV") pilot project that aims to provide a solution for natural gas utilities to directly power both residential and commercial businesses. AFCP is a diversified investment platform developing affordable, renewable, and reliable energy assets and cleantech. The JV is intended to provide proof of concept for each company's technologies and assess the ability to combine various Progressus technologies with AFCP fuel cells to serve residential and small building customers across North America. PowerTap owns 49% of Progressus.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
dynaCERT's Program with Alectra Utilities Corporation Achieves Coveted Sustainability Award

dynaCERT's Program with Alectra Utilities Corporation Achieves Coveted Sustainability Award

dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) (" dynaCERT " or the "Company") is pleased to announce that yesterday the Windfall Ecology Centre, a Canadian non-profit social enterprise, has recognized Alectra Utilities Corporation ("Alectra") for its use of dynaCERT' s HydraGEN™ Technology to reduce the emissions and fuel costs of fleet vehicles.

Alectra is the largest municipally owned electric utility in Canada by customer base. See: https://alectrautilities.com/

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
BriaCell to Present New Clinical Data at the 2022 San Antonio Breast Cancer Symposium® December 6th and 7th

BriaCell to Present New Clinical Data at the 2022 San Antonio Breast Cancer Symposium® December 6th and 7th

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company") a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, is pleased to announce that its lead product candidate, Bria-IMT™, will be featured in three posters during the 2022 San Antonio Breast Cancer Symposium® taking place December 6-10, 2022 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.

"Our mission is to find solutions for advanced breast cancer patients who do not respond to current treatments. We are thrilled for the opportunity to share our clinical findings with clinicians who treat similar, difficult-to-treat patients," stated Dr. Bill Williams, BriaCell's President & CEO.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
GMG Acquires THERMAL-XR Manufacturing Intellectual Property and Brand Rights and Grants RSUs to Directors and Officers

GMG Acquires THERMAL-XR Manufacturing Intellectual Property and Brand Rights and Grants RSUs to Directors and Officers

Graphene Manufacturing Group Ltd. (TSXV: GMG) ("GMG") is pleased to announce that, further to its news release dated August 15, 2022, GMG has completed the acquisition of the manufacturing intellectual property and brand rights of OzKem Pty Ltd.'s ("OzKem") THERMAL-XR® coating products. OzKem developed the THERMAL-XR® coating system products using GMG graphene together with OzKem's base HVAC (Heating Venting and Air Conditioning) coating. GMG is an international distributor of THERMAL-XR® products with a number of global commercial demonstrations underway or initial sales completed. GMG now owns the THERMAL-XR® brand, will buy the base coatings product from OzKem, and will manufacture the THERMAL-XR® products containing GMG graphene.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Nano One and Euro Manganese Validate Manganese Metal in M2CAM Process

Nano One and Euro Manganese Validate Manganese Metal in M2CAM Process

nano one ® Materials Corp. (TSX: NANO; OTC: NNOMF; Frankfurt: LBMB) ("nano one")

VANCOUVER, British Columbia, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) ("Euro Manganese")

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×